Press Release
Blueshift Announces the Opening of New Facilities
Sunnyvale, CA - May 1st, 2006 Blueshift Biotechnologies, Inc. announced their move to a an expanded facility within Silicon Valley. The new facility offers 9100 sg ft of space including Class 10,000 manufacturing and a full cell biology and applications development lab. "We are excited to expand our ability to meet the requirements of our customers." Said Evan Cromwell, President of Blueshift Biotechnologies. "This high quality laboratory, R&D, and manufacturing space will allow us to continue to grow and expand our product offering."
The move comes following the recent closing of a Series B investment. The new facility will provide the space needed to accommodate Blueshift's rapid growth since it's founding in 2003. The first product, the IsoCyteª , was launched at the beginning of 2005. The instrument is a bench top fluorescence laser scanning imager with the unique ability to generate two-dimensional anisotropy data shown to enable the imaging of FRET in live cells at high throughput screening rates.
The new address is:
245 Santa Ana Ct.
Sunnyvale, CA 94085
Phone- (408) 773-1050
Fax- (408) 773-1164
About Blueshift Biotechnologies
Blueshift Biotechnologies, Inc. is a privately funded technology company headquartered in the San Francisco Bay Area. Blueshift has adapted semiconductor inspection technology to new screening platforms for life sciences research. The platforms are based on Dynamic Fluorimetry™, which denotes measurements beyond intensity and color: specifically anisotropy and lifetime. Measurements made from these methods provide information on the local environment and binding state of molecules. Blueshift Biotechnologies is developing strategic alliances for products important to genomic, proteomics, cytomics, and diagnostic applications. Additional information about Blueshift Biotechnologies can be obtained at www.blueshiftbiotech.com.
Blueshift Biotechnologies, Inc. Contact:
Blueshift Biotechnologies, Inc.
Chris Shumate, 530-613-1062